Over the last 40 years the prevalence of obesity has reached epidemic proportions in North America and Europe, and is now spreading to a number of developing countries. An example of this is the observation 1 that the majority (b 60%) of Mexican-American and non-Hispanic black adults living in the USA are overweight or obese (body mass index (BMI) b 25), while 22% of all US adults are obese (BMI b 30). In Denmark, the prevalence of obesity has also increased dramatically, particularly in adolescents. This is illustrated by the prevalence of obesity in young men attending draft board examinations, which has increased from 0.1 to 5% in the post-war years ± that is the equivalent of a 50-fold increase. 2 In the coming decades these cohorts can be expected to exhibit a signi®cant morbidity and premature mortality. Although there is good evidence that a low level of physical activity and a fat-rich, energy-dense diet contributes to the development of obesity among genetically predisposed subjects, 3 it is probable that other, as yet unidenti®ed, contributory factors also play a role.
Recently, researchers at the University of Wisconsin Medical School observed that a new type of adenovirus, which normally affects birds, can produce obesity in chickens inoculated with the virus. They subsequently screened several human adenoviruses from a family of approximately 50 different airborne viruses which can cause upper respiratory infections, in¯uenza and conjunctivitis. The researchers found that one particular adenovirus, type 36 (AD-36), could cause obesity when injected into chickens. 4 When infected with AD-36, other laboratory animals, including mice, also developed obesity. 5 To study whether AD-36 could play a role in the development of obesity in humans, the researchers tested 154 obese and 45 normal weight subjects for the presence of AD-36 antibodies in the blood. They found that 15% of the obese subjects carried antibodies, while none were tested positive in the lean control group. 6 In a subsequent weight reduction programme, the obese seropositive male patients achieved a signi®cantly better weight loss (17.8% vs 11.1%) than the seronegative patients. 7 The presence of antibodies was not a prognostic marker for weight loss among females. These ®ndings suggest that the obesity of the seropositive patients could have been caused by an earlier infection with AD-36, and that this type of obesity, at least in men, is less resistant to treatment than obesity due to other causes. While carrying out these studies on AD-36, the same group was also looking at another avian virus, SMAM-1, that causes an unusual deposition of intra-abdominal fat in chickens infected with SMAM-1. 8 In 52 obese subjects, 10 (19%) were found to be seropositive for SMAM-1 antibodies, and these 10 subjects had a signi®cantly higher BMI (35.3) than the seronegative obese subjects (BMI 30.7; P`0.001).
Not surprisingly, the ®rst presentations of these results at scienti®c meetings and their dissemination in the media were met with some scepticism, but the sceptics should keep in mind the analogy with gastric ulcers. The identi®cation of the association between Helicobacter pylori and chronic gastritis and ulcers in 1983 demonstrated the infectious aspect of the disease and fundamentally changed our understanding of both its pathogenesis and its treatment. Thus, it is not inconceivable that an infection hypothesis could have similar relevance and importance for improving our understanding and treatment of the epidemic of obesity. Although it would be premature to characterise these recent ®ndings as anything more than the basis for a hypothesis, it is worth recalling that this is not the ®rst time that a virus has been implicated in obesity. Some years ago, a group from Rockefeller University 9 reported an obesity syndrome in mice infected with canine distemper virus. Nevertheless, these animal studies differ from the human studies, since the latter are exclusively observational in nature and the case-referent design is highly susceptible to confounding in¯uences. For example, an alternative to the etiological hypothesis is that the presence of antibodies in some (15±20%) obese subjects could relate to genetic and/or environmental factors that also predispose to obesity. Alternatively, the appearance of antibodies may be linked to any of the various consequences or complications of obesity which could increase the susceptibility to infection with these viruses.
Clearly, further studies are needed to con®rm these results, with a strict control of confounding factors, in other cohorts of obese subjects. In addition, longitudinal population surveys would be required to elucidate whether seropositive subjects for either or both viruses are at increased risk of spontaneous weight gain, since this would tell us whether the infection precedes the weight change. Veri®cation of the results in animals, that are metabolically more like humans than rodents or chickens, would strengthen the hypothesis and pave the way for a better understanding of the mechanisms by which the virus can change metabolism and appetite. In this respect, companion animals such as dogs may be particularly appropriate since the observed association between obesity in dogs and obesity in their owners 10 could be as much due to a shared environmental exposure to infectious agents as to shared eating habits.
To conclude, we think it unfortunate that the presentation of the results (mainly preliminary) linking human obesity with an infectious agent has attracted an inappropriate degree of media interest, but this should not dissuade more restrained and scienti®c investigators from giving the hypothesis serious attention.
